Advances in “Liquid Biopsy” and Circulating Tumor DNA
From UF Health MedEd Cast by UF Health Shands Hospital
December 3, 2025
About this episode
Dr. Peter Dziegielewski explores the innovative approach of liquid biopsy in cancer diagnosis and its applications.
In this episode, Dr. Peter Dziegielewski explores the concept of liquid biopsy—an innovative approach to cancer diagnosis. Learn about its applications in tracking treatment efficacy, monitoring minimal residual disease, and the evolving role of circulating tumor DNA. This episode is essential for anyone interested in the future of oncology. Don’t forget to subscribe for more insights!
Topics covered
- liquid biopsy
- circulating tumor DNA
- cancer diagnosis
- oncology
Keywords
- treatment efficacy
- minimal residual disease
More episodes of UF Health MedEd Cast
- Focused Ultrasound · May 28, 2026
- It Goes Beyond the Game: Dr. Farmer's Role within the UF Athletic Association · May 13, 2026
- It Goes Beyond the Game: Dr. Zaremski’s Trip to Turkey for the U16 National Girls' Soccer Team · May 4, 2026
- The Role of Short Telomere Syndrome in Lung Transplant Outcomes · April 28, 2026
- University of Florida Neuro Research Ranks No. 2 Nationally in NIH Funding · April 7, 2026
- What Makes a Center of Excellence in Endometriosis Care? · February 19, 2026
Explore listener stats, chart rankings, contacts and more on the UF Health MedEd Cast podcast page.